7 months ago
1
The Maharashtra Food and Drug Administration (FDA) urged the nationalist connected Monday (October 6, 2025) to instantly halt the merchantability and usage of a circumstantial batch of the Coldrif syrup, pursuing reports of kid deaths successful Madhya Pradesh and Rajasthan, allegedly linked to the medicine.
The entreaty comes amid increasing concerns implicit an adulterated batch of the syrup. The FDA had issued an urgent advisory earlier connected Sunday (October 5, 2025), calling for the contiguous suspension of sale, distribution, and usage of Coldrif Syrup.
The affected batch (Coldrif Syrup (Phenylephrine Hydrochloride, Chlorpheniramine Maleate), Batch No. SR-13) was manufactured successful May 2025 by Sresan Pharma, based successful Sunguvarchatram, Kancheepuram district, Tamil Nadu. The batch is acceptable to expire successful April 2027. Laboratory investigation revealed the beingness of Diethylene Glycol (DEG), a toxic chemic commonly recovered successful concern products specified arsenic anti-freeze. Ingestion of DEG tin origin kidney nonaccomplishment and has been linked to aggregate deaths.
Speaking to The Hindu, FDA Joint Commissioner (Drugs) D.R. Gahane said, “Our State and citizens are safe. We held a gathering with the Drug Control Authorities successful Tamil Nadu to hint the organisation of the batch successful Maharashtra. They confirmed that Coldrif cough syrups were not supplied successful the State. It is hard to hint whether idiosyncratic travelled from Maharashtra to neighbouring States, bought the cough syrup and brought it here. Nevertheless, we issued the connection successful the nationalist involvement and safety.”
The FDA has instructed each pharmacies, hospitals, wholesalers, and licence holders to instantly halt handling the affected batch and study immoderate banal to section cause power authorities. Citizens tin besides study possession of the syrup via the toll-free number: 1800222365, email ID: jchq.fda-mah@nic.in, oregon mobile: 9892832289.
Drug Inspectors and Assistant Commissioners person been deployed to alert marketplace stakeholders and guarantee immoderate remaining banal remains frozen. The Central Drugs Standard Control Organisation (CDSCO) is expected to instrumentality strict enactment against the shaper and has asked Tamil Nadu’s FDA to bash the same.
The nationalist alert besides stated that each licensees and users are instructed to instantly halt the sale, organisation oregon usage of Coldrif Syrup, Batch No. SR-13, and study those successful possession of the syrup to the section Drugs Control Authorities without delay.
The incidental has triggered responses crossed respective States. Madhya Pradesh has imposed a implicit prohibition connected the syrup pursuing the deaths of aggregate children successful Chhindwara district. Rajasthan has suspended its State cause controller and halted the organisation of each medicines from different manufacturer, Kaysons Pharma, portion forming an adept committee to investigate.
The Union Health Ministry has besides recommended that cough and acold medications not beryllium prescribed to children nether 2 years of property and has issued guidance to wellness departments crossed each States and Union Territories.
